1. Introduction {#sec1}
===============

Bleb-related endophthalmitis (BRE) that develops after glaucoma surgery is an infection caused by bacteria in the avascular bleb gaining access into the eye. BRE is a disease with poor visual outcome. Visual acuity is maintained at 20/400 or better in 22 to 57% of eyes after onset of endophthalmitis \[[@B1]\]. BRE is classified into several stages: stage I is blebitis, stage II is endophthalmitis involving mainly the anterior chamber, and stages IIIa and IIIb are endophthalmitis involving the vitreous \[[@B2]\]. A multicenter 5-year follow-up study in Japan reported an overall incidence of bleb-related endophthalmitis (all stages) of 2.2%, with 48% of the cases in stage I, 29% in stage II, 9% in stage IIIa, and 14% in stage IIIb. \[[@B3]\] The incidence of BRE in other countries has been reported to range from 0.45 to 1.1% \[[@B4]--[@B6]\] and is lower compared to that in Japan. A reason for the higher incidence in Japan is due to the use of trabeculectomy with mitomycin C in all the cases surveyed. Although the use of mitomycin C, an antimetabolite, improves bleb survival and maintains a low filtering bleb \[[@B7]\], the resulting bleb tends to have a thin wall and few blood vessels. As a result, the risk of bleb leakage and infection is increased. There is a concern that the incidence of late-onset BRE will increase in the future \[[@B8]\]. For the treatment of BRE, while frequent instillation of antibiotic eye drops and intravitreal antibiotic injection can be used up to stage IIIa, vitrectomy is required when the endophthalmitis reaches stage IIIb \[[@B9]\]. According to previous reports, development of stage IIIb BRE is very rare, with an incidence of 0.08 to 0.3% \[[@B3], [@B4]\].

In infectious endophthalmitis including BRE, it is known that invasion and proliferation of bacteria and fungi inside the eye exacerbates inflammation \[[@B10], [@B11]\]. Previously, we studied endogenous endophthalmitis caused by translocation of bacteria or fungi from other organs into the intraocular space. When we performed vitrectomy on patients with endogenous endophthalmitis, we found that posterior vitreous detachment (PVD) was absent in 80% of the eyes \[[@B12]\]. When formed vitreous is in contact with the posterior pole, the vitreous body acts as a culture medium for invading microorganisms, which probably increases the severity of endophthalmitis.

In the present study, we studied 10 consecutive cases of severe BRE (stage IIIb) which is a rare disease. We report the clinical characteristics, outcome, and status of posterior vitreous detachment in these eyes.

2. Methods {#sec2}
==========

Ten consecutive patients (10 eyes) diagnosed with severe BRE (stage IIIb) at the Tokyo Medical University Hospital between April 2013 and May 2015 were studied. The patients comprised 8 males and 2 females with the mean age of 70.6 ± 12.4 years at onset of BRE. The glaucoma types were primary open-angle glaucoma (POAG) in 7 patients, neovascular glaucoma secondary to central retinal vein occlusion in 2 patients, and secondary glaucoma associated with uveitis in 1 patient ([Table 1](#tab1){ref-type="table"}).

The items examined were causative microorganisms, history of surgery before onset of endophthalmitis, clinical findings, chronic use of antibiotic eye drops, surgical method, status of posterior vitreous detachment (PVD), and pre- and postoperative visual acuity. Clinical findings focused on avascular bleb, leakage of aqueous humor from the filtering bleb, fibrin deposition, hypopyon, and intraocular lens (IOL) implantation. Posterior vitreous detachment was defined as detachment of the vitreous body around the optic disc or in the vascular arcade.

All vitrectomies were conducted using a 25-gauge Constellation Vision System (Alcon Laboratories Inc.). Balanced salt solution (BSS) containing ceftazidime (20 mg/ml) and vancomycin (1 mg/ml) was used as the irrigation solution. For isolation and identification of causative microorganisms, the vitreous fluid sample was collected during vitrectomy and used in culture, smear, and microscopic examinations.

2.1. Statistical Analyses {#sec2.1}
-------------------------

Data are expressed as mean ± standard deviation. Preoperative and postoperative visual acuity was compared using the Student\'s *t*-test. Statistical analysis was performed using MedCalc statistical software version 12.1.1 (MedCalc software, Mariakerke, Belgium). A *p* value less than 0.05 was considered significant.

3. Results {#sec3}
==========

Bacteria were isolated from vitreous samples collected during vitrectomy or from the enucleated eye in 8 of 10 eyes. The bacteria were identified as *Viridans streptococci* in 5 eyes, *Branhamella catarrhalis* in 1 eye, *Staphylococcus epidermidis* in 1 eye, and coagulase-negative Staphylococci in 1 eye. No bacteria were detected in 2 eyes ([Table 2](#tab2){ref-type="table"}).

The surgical history (multiple surgeries in some eyes before onset of endophthalmitis) was trabeculectomy + phacoemulsification and aspiration + IOL implantation in 5 eyes, trabeculectomy alone in 5 eyes, trabeculectomy following phacoemulsification and aspiration + vitrectomy in 1 eye. One patient performed trabeculectomy twice. All trabeculectomies were fornix-based with mitomycin C augmentation. The mean interval from the last trabeculectomy to onset of endophthalmitis was 8.5 ± 4.1 (range 4--15) years. At presentation to the Department of Ophthalmology, the mean visual acuity (logMAR) was 2.46 ± 0.74, and mean intraocular pressure was 14.0 ± 10.5 mmHg. Examination of the anterior chamber revealed avascular bleb, leakage of aqueous humor from the filtering bleb, and fibrin deposition in all eyes, hypopyon in 4 eyes, and IOL implantation in 6 eyes. In this study, chronic use of antibiotics, defined as continuous use for 1 year prior to onset of BRE, was found in 6 patients (60%).

In one patient who presented with no light perception and severe pain, enucleation of the eyeball was conducted ([Table 1](#tab1){ref-type="table"}). In the remaining 9 eyes, BRE was treated by IOL removal + vitrectomy in 3 eyes, vitrectomy alone in 3 eyes, and phacoemulsification without IOL plantation and aspiration + vitrectomy in 3 eyes, including repeat vitrectomy in 1 eye to resolve infection.

The changes in visual acuity from before to after treatment for BRE in 9 eyes are shown in [Figure 1](#fig1){ref-type="fig"}. When visual improvement was defined as a decrease in logMAR of 0.3 or more, posttreatment visual acuity was improved in 6 eyes and unchanged in 3 eyes, with no deterioration. This result confirmed that vitrectomy for BRE was effective to a certain extent in improving or maintaining visual acuity.

Among 9 eyes that underwent vitrectomy, PVD was produced during vitrectomy in 6 eyes. The mean age of patients in whom PVD had occurred before vitrectomy (73.0 ± 16.6 years) was not different from the age of those without PVD (69.2 ± 12.7 years) ([Table 3](#tab3){ref-type="table"}). In 1 eye that was enucleated because of severe pain and no light perception at presentation, examination of the enucleated eye also showed no PVD ([Figure 2](#fig2){ref-type="fig"}).

4. Discussion {#sec4}
=============

Bleb-related endophthalmitis occurring with late onset after glaucoma surgery is the postoperative complication that results in the worst outcome. According to the Collaborative Bleb-related Infection Incidence and Treatment Study (CBIITS) conducted in Japan, the incidence of bleb-related infection that progressed to stage IIIb endophthalmitis in a 5-year follow-up was 0.31% \[[@B3]\]. In the present study, 6 of 9 eyes with BRE treated with vitrectomy achieved improvement of visual acuity of three lines or more. While this finding shows a certain degree of effectiveness of vitrectomy for BRE, it also confirms that BRE remains a disease with poor visual outcome. Various risk factors for the development of BRE have been reported, including nasal and inferior blebs \[[@B13]\], leakage from the filtering bleb and hypotony \[[@B8], [@B14]\], limbus-based trabeculectomy \[[@B15]\], aphakic eye, IOL implantation \[[@B1], [@B3]\], and chronic use of eye drops \[[@B16]\].

In endophthalmitis that occurs after cataract surgery, because the most frequent causative microorganism is *Staphylococcus epidermidis*, a less virulent bacteria species, the visual outcome after endophthalmitis is relatively favorable \[[@B17], [@B18]\]. For early-onset BRE that develops within 6 weeks after glaucoma surgery, *Staphylococcus epidermidis* is also known to be a frequent causative bacterial species, as in endophthalmitis after cataract surgery. On the other hand, BRE that develops later than 6 weeks after glaucoma surgery is often caused by more virulent microorganisms such as *Streptococcus* species and Gram-negative bacteria, with markedly poorer visual outcome \[[@B1], [@B19]\]. In the present study also, *Viridans streptococci* were isolated from 50% of the cases. However, less virulent bacteria or normal microflora such as coagulase-negative Staphylococci and *Staphylococcus epidermidis* also caused severe endophthalmitis in our study.

In a previous study, we found that PVD was absent in 8 of 10 consecutive eyes in which vitrectomy was performed for endogenous endophthalmitis \[[@B12]\]. In the present series of BRE, we also found that PVD did not occur spontaneously in 7 of 10 eyes. Moreover, in one enucleated eye, the absence of PVD was confirmed by histopathological examination. The mean age of BRE onset in all 10 patients (70.6 ± 12.4 years) was not significantly different from that of the PVD-negative patients (69.2 ± 8.4 years). Our patients were older than the reported mean age of spontaneous occurrence of PVD (54 to 57 years). Therefore, we speculate that the presence or absence of PVD may be related to the pathogenesis of endophthalmitis. A previous study indicated a relation between the presence of vitreous body and proliferation of bacteria \[[@B20]\]. In addition, the severity of endophthalmitis is known to depend on the virulence of the causative bacteria. Our findings that even bacteria with low virulence and normal microflora caused severe BRE and that PVD was absent even at an old age suggest that the vitreous body may be involved not only in proliferation but also in migration for causative microorganisms. It is possible that in the presence of the vitreous body, bacteria that have gained access into the eye from the aqueous humor leakage site of the avascular bleb can be transmitted through the vitreous body to the retina, facilitating the establishment of retinal infection. Upon reaching the posterior segment of the eye, transmission may occur through the Cloquet\'s canal \[[@B21]\] or via the posterior vitreous cortex in contact with the retina, although these mechanisms remain to be elucidated. In other words, the absence of PVD may be a risk factor of severe BRE. In the future, with an increase in number of patients who undergo trabeculectomy with mitomycin C and aging of these patients, there is a concern that the incidence of BRE may increase. Currently, visualization of the vitreous body by optical coherence tomography has become possible. Regular follow-up for the presence or absence of PVD may be necessary in patients who have undergone trabeculectomy. In addition, the possibility of using vitreolytic agents such as ocriplasmin \[[@B22]\] to prevent onset of BRE has to be examined.

The present study confirms the absence of PVD in a large proportion of eyes with severe BRE and suggests a relationship between the absence of PVD and pathogenesis of endophthalmitis.
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###### 

Clinical data of patients with bleb-related endophthalmitis.

  Case   Age (years)   Gender   Type of glaucoma   Treatment           Preoperative VA   Postoperative VA   Postlectomy (years)   Avascular bleb   Bleb leakage   Chronic use of antibiotics
  ------ ------------- -------- ------------------ ------------------- ----------------- ------------------ --------------------- ---------------- -------------- ----------------------------
  1      75            Male     SG (uveitis)       Vit                 HM                HM                 8                     \+               \+             \+
  2      80            Male     NVG                IOL removal + Vit   HM                20/2000            6                     \+               \+             −
  3      82            Male     NVG                PEA-Vit             20/50             20/50              9                     \+               \+             \+
  4      53            Female   POAG               Vit                 HM                20/30              10                    \+               \+             \+
  5      72            Male     POAG               Enucleation         sl(−)             sl(−)              15                    \+               \+             \+
  6      83            Male     POAG               Vit                 HM                HM                 16                    \+               \+             \+
  7      64            Male     POAG               IOL removal + Vit   HM                0.6                4                     \+               \+             −
  8      54            Male     POAG               PEA-Vit             HM                20/30              6                     \+               \+             \+
  9      85            Female   POAG               IOL removal + Vit   HM                20/30              5                     \+               \+             −
  10     58            Male     POAG               PEA + Vit           sl(+)             20/200             6                     \+               \+             −

SG, secondary glaucoma; NVG, neovascular glaucoma; POAG, primary open-angle glaucoma; Vit; vitrectomy; PEA, phacoemulsification and aspiration; IOL, intraocuar lens; VA, visual acuity; HM, hand motion; sl, sensus luminis.

###### 

Culture results of vitreous samples.

  Causative bacteria                  Number of eyes
  ----------------------------------- ----------------
  Bacteria detected                   8
   *Viridans streptococci*            5
   *Branhamella catarrhalis*          1
   *Staphylococcus epidermidis*       1
   Coagulase-negative Staphylococci   1
  No bacteria detected                2

###### 

Ages of patients with and without posterior vitreous detachment at vitrectomy.

           Number   Age (mean ± standard deviation)
  -------- -------- ---------------------------------
  PVD(−)   6        69.2 ± 12.7
  PVD(+)   3        73.0 ± 16.6

PVD; posterior vitreous detachment.
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